You are here

Tonsil-derived MSCs in Tissue Regeneration

A recent concise review article in STEM CELLS from the laboratory of Inho Jo (Ewha Womans University, Seoul, Republic of Korea) summarizes the differentiation capacities of tonsil‐derived mesenchymal stem cells (MSCs) and their therapeutic competencies. Oh et al. believe that tonsil-derived MSCs could be an attractive choice for clinical applications because of their non‐invasive collection, relatively high proliferation rate, low allogenicity and their ability to differentiate into mesodermal, endodermal, and ectodermal lineages.